SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-21-026519
Filing Date
2021-05-14
Accepted
2021-05-14 17:07:48
Documents
4

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140936-8k_gxacquisit.htm 425 47728
2 LETTER AGREEMENT BY AND AMONG GX ACQUISITION CORP., ALPHA FIRST MERGER SUB, INC. ea140936ex2-1_gxacquisit.htm EX-2.1 20416
3 AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF GX ACQUISITION ea140936ex3-1_gxacquisit.htm EX-3.1 10080
4 PRESS RELEASE ISSUED MAY 14, 2021 ea140936ex99-1_gxacquisit.htm EX-99.1 16668
  Complete submission text file 0001213900-21-026519.txt   96494
Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Acquisition Corp. (Filed by) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF THE AMERICAS 25TH FLOOR NEW YORK NY 10019 2126163700
GX Acquisition Corp. (Subject) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-38914 | Film No.: 21925854
SIC: 2834 Pharmaceutical Preparations